Recent News

• 06.09.2025 - Portage Biotech and Compedica Stock-for-Stock Exchange
• 06.09.2025 - Portage Biotech and Compedica Stock-for-Stock Exchange
• 04.28.2025 - Portage Biotech Reports Confirmatory Preclinical Results in Mesothelioma Supporting First-In-Human Trial of PORT-7
• 04.28.2025 - Portage Biotech Reports Confirmatory Preclinical Results in Mesothelioma Supporting First-In-Human Trial of PORT-7
• 03.27.2025 - Portage Biotech Reports Promising Preclinical Results in Mesothelioma Supporting First-In-Human Trial of PORT-7
• 03.27.2025 - Portage Biotech Reports Promising Preclinical Results in Mesothelioma Supporting First-In-Human Trial of PORT-7

Recent Filings

• 06.09.2025 - EX-99.1 EX-99.1
• 06.09.2025 - 424B3 Prospectus [Rule 424(b)(3)]
• 06.09.2025 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
• 05.29.2025 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
• 05.29.2025 - 424B3 Prospectus [Rule 424(b)(3)]
• 05.21.2025 - 424B2 Prospectus [Rule 424(b)(2)]
• 05.14.2025 - EFFECT Notice of Effectiveness
• 05.12.2025 - F-3/A Registration statement by foreign private issuers
• 05.05.2025 - F-3 Registration statement by foreign private issuers
• 04.28.2025 - 424B3 Prospectus [Rule 424(b)(3)]